Biotechnology ASH24: Darzalex in smoldering myeloma, Merck’s ADC data and Novo’s sickle cell drug J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH mid-stage findings for important new medicines. Written by Ned Pagliarulo, Jonathan Gardner and Ben Fidler December 10, 2024December 10, 2024 Saving Bookmark this article Bookmarked
Biotechnology Excipient Use in Biopharmaceuticals: Key Insights – ChemIntel360 Originally published at Get our excipient business reports at and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/ The biopharmaceutical industry has witnessed significant advancements over the past few decades, with excipients playing a crucial role in the formulation and stability of therapeutic drugs. Excipients, often considered the unsung heroes of drug development, are essential components that […] Written by ChemIntel360 December 6, 2024December 6, 2024 Saving Bookmark this article Bookmarked
Biotechnology A new era in immunotherapy Cancer vaccines represent an increasingly important area of biotech in oncology, using the body’s immune system to combat cancer cells. They are broadly categorized into two types: preventive and therapeutic vaccines. Preventive vaccines are designed to avert cancer development by targeting infections that can lead to cancer. Some examples of these are human papillomavirus (HPV) […] Written by Jules Adam December 3, 2024December 3, 2024 Saving Bookmark this article Bookmarked
Biotechnology Cradle Secures $73m Series B to Accelerate AI-Driven Protein Engineering Cradle, the pioneering platform for AI-powered protein engineering in Amsterdam, Netherlands, has successfully raised US$73m in Series B funding. The round, led by IVP with participation from existing investors Index Ventures and Kindred Capital, brings the company’s total funding to over US$100m. Cradle’s generative AI platform is already used across multiple industries, including pharmaceuticals, agriculture, […] Written by Georg Kääb November 30, 2024November 30, 2024 Saving Bookmark this article Bookmarked
Biotechnology Amgen obesity drug cuts weight in study, but results miss Wall Street’s high mark Shares in Amgen fell by double digits Tuesday on long-awaited results for the company’s monthly MariTide shot, which is viewed as a potential rival to Wegovy and Zepbound. Written by Jonathan Gardner November 26, 2024November 26, 2024 Saving Bookmark this article Bookmarked
Biotechnology Which pharmaceutical drugs have the most drug patents in United Kingdom? Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ This chart shows the drugs with the most patents in United Kingdom. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired. The companies with the greatest patent coverage in United Kingdom are: Onzetra Xsail Xhance Evzio Evzio (autoinjector) […] Written by DrugPatentWatch – Make Better Decisions November 23, 2024November 23, 2024 Saving Bookmark this article Bookmarked
Biotechnology Six bispecific antibody companies you should know about Bispecific antibodies seem to be all the rage at the minute. Their ability to deliver targeted therapeutics to patients with a two-in-one approach by simultaneously binding to two different antigens or epitopes makes them an extremely attractive proposition to drug developers. This can be seen in the fact that there have been multiple big buyouts […] Written by Willow Shah-Neville November 20, 2024November 20, 2024 Saving Bookmark this article Bookmarked
Biotechnology Tetraspecific B/NK cell better than T cell engagers The therapeutic landscape for relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) is evolving toward targeted T-cell based immunotherapies, including CD19-targeted CAR-T and CD3xCD20 T-cell engaging (TCE) bispecificantibodies. Yet, there remains an unmet medical need for patients who are refractory to, or ineligible for these treatments. Leveraging natural killer NK cells emerges as a promising […] Written by Thomas Gabrielczyk November 16, 2024November 16, 2024 Saving Bookmark this article Bookmarked
Biotechnology GSK partners with Flagship startup to hunt for Parkinson’s drugs Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for Parkinson’s and another neurodegenerative condition. Written by Gwendolyn Wu November 13, 2024November 13, 2024 Saving Bookmark this article Bookmarked
Biotechnology New tentative approval for Alembic drug dabigatran etexilate mesylate Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/ Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs. There are three patents protecting this compound. Drug patent litigation for DABIGATRAN ETEXILATE MESYLATE. Nine suppliers are […] Written by DrugPatentWatch – Make Better Decisions November 10, 2024November 10, 2024 Saving Bookmark this article Bookmarked
The 4x rule: Why some people’s DNA is more unstable than others A large scale genetic analysis of more than 900,000 people has revealed that specific regions of DNA become increasingly unstable over time. These regions are made up of very short sequences that repeat again and again, and the study shows that they tend to grow longer as people age. Researchers also found that common inherited […] Written by Admin January 10, 2026January 10, 2026 Saving Bookmark this article Bookmarked
Mitochondrial presequences harbor variable strengths to maintain organellar function Hundreds of mitochondrial proteins rely on N-terminal presequences for organellar targeting and import. While generally described as positively charged amphiphilic helices, presequences lack a consensus motif and thus likely promote protein import into mitochondria with variable efficiencies. Indeed, the concept of presequence strength underlies biological models such as stress sensing, yet a quantitative analysis of […] Written by Admin January 9, 2026January 9, 2026 Saving Bookmark this article Bookmarked
The 4x rule: Why some people’s DNA is more unstable than others A large scale genetic analysis of more than 900,000 people has revealed that specific regions of DNA become increasingly unstable over time. These regions are made up of very short sequences that repeat again and again, and the study shows that they tend to grow longer as people age. Researchers also found that common inherited […] Written by Admin January 10, 2026January 10, 2026 Saving Bookmark this article Bookmarked
Mitochondrial presequences harbor variable strengths to maintain organellar function Hundreds of mitochondrial proteins rely on N-terminal presequences for organellar targeting and import. While generally described as positively charged amphiphilic helices, presequences lack a consensus motif and thus likely promote protein import into mitochondria with variable efficiencies. Indeed, the concept of presequence strength underlies biological models such as stress sensing, yet a quantitative analysis of […] Written by Admin January 9, 2026January 9, 2026 Saving Bookmark this article Bookmarked
Labour’s ‘deeply alarming’ attack on protest rights British authorities have severely restricted the right to protest in contravention of their international human rights obligations, creating an environment in which peaceful dissent is increasingly treated as a criminal act, Human Rights Watch said in its latest report. ‘Silencing the Streets’: The Right to Protest Under Attack in the UK documents that the UK’s […] Written by brendan January 9, 2026January 9, 2026 Saving Bookmark this article Bookmarked
Understanding PMDA Validation Rules v5.0 The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan has always led the charge in ensuring the safety and efficacy of drug development. Their latest update, the PMDA Validation Rules version 5.0, which took effect on April 1, 2024, marks another significant step in this mission. Let’s break down what these new rules mean and […] Written by Admin July 10, 2024July 10, 2024 Saving Bookmark this article Bookmarked
Enhance Your SEND Submissions! Join PointCross on May 29th, 2024, at 12 PM EST / 9 AM PST for a must-attend webinar: The Most Common Issues in Preparing SEND. Ideal for professionals in data submission and regulatory compliance, this webinar offers valuable insights from our seasoned experts. Why Attend? Why PointCross? With over 10 years of experience and more […] Written by Admin May 23, 2024May 23, 2024 Saving Bookmark this article Bookmarked